Patrick J. Earley
Corporate Officer/Principal bei CTI Clinical Trial & Consulting Services, Inc.
Profil
Patrick J.
Earley is currently the Chief International Business Officer at CTI Clinical Trial & Consulting Services, Inc. He holds a Master's in Business Administration from Xavier University and an undergraduate degree from West Liberty State College (West Virginia).
Aktive Positionen von Patrick J. Earley
| Unternehmen | Position | Beginn |
|---|---|---|
CTI Clinical Trial & Consulting Services, Inc.
 CTI Clinical Trial & Consulting Services, Inc. Miscellaneous Commercial ServicesCommercial Services CTI Clinical Trial & Consulting Services, Inc. engages in the provision o clinical trial and consulting services. It offers multi-specialty clinical research site that conducts phase I-IV trials. The firm focuses in therapeutic approach for pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine and gene therapy, immunology, transplantation, nephrology, hematology and oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. The company was founded by Timothy J. Schroeder and Lynn Fallon in 1999 and is headquartered in Covington, KY. | Corporate Officer/Principal | 13.05.2014 |
Ausbildung von Patrick J. Earley
| Xavier University | Masters Business Admin |
| West Liberty State College (West Virginia) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
CTI Clinical Trial & Consulting Services, Inc.
CTI Clinical Trial & Consulting Services, Inc. Miscellaneous Commercial ServicesCommercial Services CTI Clinical Trial & Consulting Services, Inc. engages in the provision o clinical trial and consulting services. It offers multi-specialty clinical research site that conducts phase I-IV trials. The firm focuses in therapeutic approach for pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine and gene therapy, immunology, transplantation, nephrology, hematology and oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. The company was founded by Timothy J. Schroeder and Lynn Fallon in 1999 and is headquartered in Covington, KY. | Commercial Services |